Watchlist Price Alert

Adamis Pharmaceuticals Co... (ADMP)

NASDAQ: ADMP · Real-Time Price · USD

0.78

0.01 (1.50%)

At close: Sep 07, 2023, 7:59 PM

Adamis Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	1.08M	23.22M	6.86M	8.81M	19.27M	17.32M	4.09M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	52.17K	109.14K	54.66K	1.65M	1.85M	54.66K	42.5K
Receivables	1.09M	5.9M	1.09M	1.88M	1.16M	830.09K	805.37K
Inventory	1.24M	418.61K	3.12M	2.06M	3.28M	1.82M	942.07K
Other Current Assets	893.93K	215.3K	13.09K	3.44K	3.44K	8.02K	42.5K
Total Current Assets	9.27M	35.2M	12.52M	13.88M	25.78M	21.46M	7.07M
Property-Plant & Equipment	1.61M	2.99M	11.13M	13.54M	9.87M	6.56M	4.9M
Goodwill & Intangibles	n/a	n/a	7.16M	18.77M	20.85M	23.33M	25.78M
Total Long-Term Assets	1.66M	3.09M	18.34M	33.96M	32.57M	29.94M	30.72M
Total Assets	10.93M	38.3M	30.87M	47.84M	58.36M	51.4M	37.79M
Account Payables	7.94M	3.75M	3.49M	4.27M	4.17M	2.92M	2.15M
Deferred Revenue	27.78K	100K	100.07K	915.67K	1.01M	14.76K	54.48K
Short-Term Debt	342.56K	349.87K	4.86M	2.6M	2.58M	2.48M	4.33M
Other Current Liabilities	3.09M	7.02M	11.47M	2.43M	3.79M	3.37M	2.08M
Total Current Liabilities	11.4M	11.22M	19.93M	10.21M	11.55M	8.79M	8.61M
Long-Term Debt	n/a	342.56K	2M	1.48M	n/a	2.58M	3.07M
Other Long-Term Liabilities	164.79K	99.66K	4.49M	4.58M	n/a	n/a	n/a
Total Long-Term Liabilities	343.04K	1.19M	7.44M	1.59M	112.53K	3.07M	3.9M
Total Liabilities	11.74M	12.42M	27.37M	11.8M	11.67M	11.86M	12.51M
Total Debt	342.56K	692.43K	6.86M	4.08M	2.58M	5.07M	7.4M
Common Stock	15.05K	15.01K	9.44K	6.24K	4.78K	3.37K	2.23K
Retained Earnings	-304.56M	-278.09M	-229.91M	-182.31M	-153M	-114M	-88.46M
Comprehensive Income	n/a	n/a	n/a	n/a	-1.58M	n/a	n/a
Shareholders Equity	-808.07K	25.88M	3.5M	36.04M	46.69M	39.55M	25.28M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a